Pneumococcal Polysaccharide Vaccine Market Report

Pneumococcal Polysaccharide Vaccine Market - Global Professional Analysis and Forecast to 2026

  • POSTDATE：Jan 14, 2020
  • PAGES：175
  • REPORT CODE：GMM435385
  • REPORT SUMMARY
  • TABLE OF CONTENTS

  • The worldwide Pneumococcal Polysaccharide Vaccine market was valued at XX.0 Million US$ in 2018 and is projected to reach XX.0 Million US$ by 2026, at a CAGR (Compound Annual Growth Rate) of 5.2% during the forecast period.

    This report presents the market size and development trends by detailing the Pneumococcal Polysaccharide Vaccine market revenue, market share and growth rate from 2015-2026, and it gives a thorough analysis by various product types, applications, regions, and main participants. The market conditions (2015-2019), corporate competition pattern, corporate SWOT analysis are elaborated, and other qualitative analyses like market dynamics, market penetration, market business environment analyses, the regional regulatory scenario in the Pneumococcal Polysaccharide Vaccine market will be shown in this report. In short, this report will comprehensively reveal the characteristics of Pneumococcal Polysaccharide Vaccine industry and will help you to build a panoramic view of the industrial development.

    Pneumococcal Polysaccharide Vaccine Market, By Type:

    • Single Dose Vial

    • Pre-Filled Syringe

    Pneumococcal Polysaccharide Vaccine Market, By Application:

    • Children (2-10 Age)

    • Adult (10-64 Age)

    • Geriatric (More Than 65 Age)

    Some of the leading players are as follows:

    • Merck & Co, Inc.

    • Merck & Co., Inc.

    • China National Biotec Group

    • Glaxosmithkline Plc.

    • Serum Institute of India Pvt. Ltd

    • Pfizer Inc

    • Astellas Pharma Inc

    Geographically, Major regions are analyzed in details are as follows:

    • North America

    • Europe

    • Asia Pacific

    • Latin America

    • Middle East & Africa

  • Table of Contents

    1 Methodology and Scope

    • 1.1 Market Segmentation & Scope

      • 1.1.1 Technology Type

      • 1.1.2 Product

      • 1.1.3 Application

      • 1.1.4 Regional scope

      • 1.1.5 Estimates and forecast timeline

    • 1.2 Research Methodology

    • 1.3 Information Procurement

      • 1.3.1 Purchased database

      • 1.3.2 Internal database

      • 1.3.3 Secondary sources

      • 1.3.4 Primary research

      • 1.3.5 Details of primary research

    • 1.4 Information or Data Analysis

      • 1.4.1 Data analysis models

    • 1.5 Market Formulation & Validation

    • 1.6 Model Details

      • 1.6.1 Commodity flow analysis

      • 1.6.2 Volume price analysis

    • 1.7 List of Secondary Sources

    • 1.8 List of Abbreviations

    2 Executive Summary

    • 2.1 Market Outlook

    • 2.2 Segment Outlook

    3 Market Variables, Trends, & Scope

    • 3.1 Market Lineage Outlook

    • 3.1.1 Parent market outlook

      • 3.1.2 Ancillary market outlook

    • 3.2 Market Segmentation

      • 3.2.1 Analysis

    • 3.3 Market Dynamics

      • 3.3.1 Market driver analysis

      • 3.3.2 Market restraint analysis

      • 3.3.3 Industry opportunities

    • 3.4 Penetration & Growth Prospect Mapping

      • 3.4.1 Penetration & growth prospect mapping analysis

    • 3.5 Business Environment Analysis Tools

      • 3.5.1 Porter's five forces analysis

      • 3.5.2 PESTLE analysis

      • 3.5.3 Major deals & strategic alliances analysis

    4 Pneumococcal Polysaccharide Vaccine Market: Technology Type Analysis

    • 4.1 Pneumococcal Polysaccharide Vaccine Technology Type Market Share Analysis, 2018 & 2026

    • 4.2 Pneumococcal Polysaccharide Vaccine Technology Type Market: Segment Dashboard

    • 4.3 Market Size & Forecasts and Trend Analyses, 2015 to 2026 for the Technology Type Segment

      • 4.3.1 Single Dose Vial

      • 4.3.2 Pre-Filled Syringe

    5 Pneumococcal Polysaccharide Vaccine Market: Product Analysis

    • 5.1 Pneumococcal Polysaccharide Vaccine Product Market Share Analysis, 2018 & 2026

    • 5.2 Pneumococcal Polysaccharide Vaccine Product Market: Segment Dashboard

    • 5.3 Market Size & Forecasts and Trend Analyses, 2015 to 2026 for the Product Segment

    6 Pneumococcal Polysaccharide Vaccine Market: Application Analysis

    • 6.1 Pneumococcal Polysaccharide Vaccine Application Market Share Analysis, 2018 & 2026

    • 6.2 Pneumococcal Polysaccharide Vaccine Application Market: Segment Dashboard

    • 6.3 Market Size & Forecasts and Trend Analyses, 2015 to 2026 for the Application Segment

      • 6.3.1 Children (2-10 Age)

      • 6.3.2 Adult (10-64 Age)

      • 6.3.3 Geriatric (More Than 65 Age)

    7 Pneumococcal Polysaccharide Vaccine Market: Regional Analysis

    • 7.1 Pneumococcal Polysaccharide Vaccine Regional Market Share Analysis, 2018 & 2026

    • 7.2 Pneumococcal Polysaccharide Vaccine Regional Market: Segment Dashboard

    • 7.3 Regional Market Snapshot (Market Size, CAGR, Top Countries)

    • 7.4 List of Players at Regional Level

      • 7.4.1 North America

      • 7.4.2 Europe

      • 7.4.3 Asia Pacific

    • 7.5 SWOT Analysis, by Factor (Political & Legal, Economic and Technological)

      • 7.5.1 North America

      • 7.5.2 Europe

      • 7.5.3 Asia Pacific

      • 7.5.4 Latin America

      • 7.5.5 MEA

    • 7.6 Market Size & Forecasts, and Trend Analysis, 2015 to 2026

      • 7.6.1 North America

      • 7.6.2 Europe

      • 7.6.3 Asia Pacific

      • 7.6.4 Latin America

      • 7.6.5 Middle East & Africa

    8 Competitive Analysis

    • 8.1 Recent Developments & Impact Analysis, by Key Market Participants

    • 8.2 Strategic Framework/Competition Categorization (Key innovators, Market leaders, Emerging players)

    • 8.3 Vendor Landscape

      • 8.3.1 Company market position analysis (Geographic presence, service portfolio, strategic initiatives)

    9 Company Profiles

    • 9.1 Merck & Co, Inc.

      • 9.1.1 Merck & Co, Inc. Company overview

      • 9.1.2 Financial performance

      • 9.1.3 Product benchmarking

      • 9.1.4 Strategic initiatives

      • 9.1.5 SWOT analysis

    • 9.2 Merck & Co., Inc.

      • 9.2.1 Merck & Co., Inc. Company overview

      • 9.2.2 Financial performance

      • 9.2.3 Product benchmarking

      • 9.2.4 Strategic initiatives

      • 9.2.5 SWOT analysis

    • 9.3 China National Biotec Group

      • 9.3.1 China National Biotec Group Company overview

      • 9.3.2 Financial performance

      • 9.3.3 Product benchmarking

      • 9.3.4 Strategic initiatives

      • 9.3.5 SWOT analysis

    • 9.4 Glaxosmithkline Plc.

      • 9.4.1 Glaxosmithkline Plc. Company overview

      • 9.4.2 Financial performance

      • 9.4.3 Product benchmarking

      • 9.4.4 Strategic initiatives

      • 9.4.5 SWOT analysis

    • 9.5 Serum Institute of India Pvt. Ltd

      • 9.5.1 Serum Institute of India Pvt. Ltd Company overview

      • 9.5.2 Financial performance

      • 9.5.3 Product benchmarking

      • 9.5.4 Strategic initiatives

      • 9.5.5 SWOT analysis

    • 9.6 Pfizer Inc

      • 9.6.1 Pfizer Inc Company overview

      • 9.6.2 Financial performance

      • 9.6.3 Product benchmarking

      • 9.6.4 Strategic initiatives

      • 9.6.5 SWOT analysis

    • 9.7 Astellas Pharma Inc

      • 9.7.1 Astellas Pharma Inc Company overview

      • 9.7.2 Financial performance

      • 9.7.3 Product benchmarking

      • 9.7.4 Strategic initiatives

      • 9.7.5 SWOT analysis

     

    The List of Tables and Figures (Totals 83 Figures and 121 Tables)

    • Figure Single Dose Vial Pneumococcal Polysaccharide Vaccine market, 2015 - 2026 (USD Million)

    • Figure Pre-Filled Syringe Pneumococcal Polysaccharide Vaccine market, 2015 - 2026 (USD Million)

    • Figure Children (2-10 Age) market, 2015 - 2026 (USD Million)

    • Figure Adult (10-64 Age) market, 2015 - 2026 (USD Million)

    • Figure Geriatric (More Than 65 Age) market, 2015 - 2026 (USD Million)

    • Table List of players in North America

    • Table List of players in Europe

    • Table List of players in Asia Pacific

    • Table SWOT analysis

    • Table North America Pneumococcal Polysaccharide Vaccine market, by country, 2015 - 2026 (USD Million)

    • Table North America Pneumococcal Polysaccharide Vaccine market, by type, 2015 - 2026 (USD Million)

    • Table North America Pneumococcal Polysaccharide Vaccine market, by product, 2015 - 2026 (USD Million)

    • Table North America Pneumococcal Polysaccharide Vaccine market, by application, 2015 - 2026 (USD Million)

    • Table Regulatory scenario

    • Table U.S. Pneumococcal Polysaccharide Vaccine market, by type, 2015 - 2026 (USD Million)

    • Table U.S. Pneumococcal Polysaccharide Vaccine market, by product, 2015 - 2026 (USD Million)

    • Table U.S. Pneumococcal Polysaccharide Vaccine market, by application, 2015 - 2026 (USD Million)

    • Table Regulatory scenario

    • Table Canada Pneumococcal Polysaccharide Vaccine market, by type, 2015 - 2026 (USD Million)

    • Table Canada Pneumococcal Polysaccharide Vaccine market, by product, 2015 - 2026 (USD Million)

    • Table Canada Pneumococcal Polysaccharide Vaccine market, by application, 2015 - 2026 (USD Million)

    • Table Europe Pneumococcal Polysaccharide Vaccine market, by country, 2015 - 2026 (USD Million)

    • Table Europe Pneumococcal Polysaccharide Vaccine market, by type, 2015 - 2026 (USD Million)

    • Table Europe Pneumococcal Polysaccharide Vaccine market, by product, 2015 - 2026 (USD Million)

    • Table Europe Pneumococcal Polysaccharide Vaccine market, by application, 2015 - 2026 (USD Million)

    • Table Regulatory scenario

    • Table U.K. Pneumococcal Polysaccharide Vaccine market, by type, 2015 - 2026 (USD Million)

    • Table U.K. Pneumococcal Polysaccharide Vaccine market, by product, 2015 - 2026 (USD Million)

    • Table U.K. Pneumococcal Polysaccharide Vaccine market, by application, 2015 - 2026 (USD Million)

    • Table Regulatory scenario

    • Table Germany Pneumococcal Polysaccharide Vaccine market, by type, 2015 - 2026 (USD Million)

    • Table Germany Pneumococcal Polysaccharide Vaccine market, by product, 2015 - 2026 (USD Million)

    • Table Germany Pneumococcal Polysaccharide Vaccine market, by application, 2015 - 2026 (USD Million)

    • Table Regulatory scenario

    • Table France Pneumococcal Polysaccharide Vaccine market, by type, 2015 - 2026 (USD Million)

    • Table France Pneumococcal Polysaccharide Vaccine market, by product, 2015 - 2026 (USD Million)

    • Table France Pneumococcal Polysaccharide Vaccine market, by application, 2015 - 2026 (USD Million)

    • Table Regulatory scenario

    • Table Italy Pneumococcal Polysaccharide Vaccine market, by type, 2015 - 2026 (USD Million)

    • Table Italy Pneumococcal Polysaccharide Vaccine market, by product, 2015 - 2026 (USD Million)

    • Table Italy Pneumococcal Polysaccharide Vaccine market, by application, 2015 - 2026 (USD Million)

    • Table Regulatory scenario

    • Table Spain Pneumococcal Polysaccharide Vaccine market, by type, 2015 - 2026 (USD Million)

    • Table Spain Pneumococcal Polysaccharide Vaccine market, by product, 2015 - 2026 (USD Million)

    • Table Spain Pneumococcal Polysaccharide Vaccine market, by application, 2015 - 2026 (USD Million)

    • Table Asia Pacific Pneumococcal Polysaccharide Vaccine market, by country, 2015 - 2026 (USD Million)

    • Table Asia Pacific Pneumococcal Polysaccharide Vaccine market, by type, 2015 - 2026 (USD Million)

    • Table Asia Pacific Pneumococcal Polysaccharide Vaccine market, by product, 2015 - 2026 (USD Million)

    • Table Asia Pacific Pneumococcal Polysaccharide Vaccine market, by application, 2015 - 2026 (USD Million)

    • Table Regulatory scenario

    • Table China Pneumococcal Polysaccharide Vaccine market, by type, 2015 - 2026 (USD Million)

    • Table China Pneumococcal Polysaccharide Vaccine market, by product, 2015 - 2026 (USD Million)

    • Table China Pneumococcal Polysaccharide Vaccine market, by application, 2015 - 2026 (USD Million)

    • Table Regulatory scenario

    • Table Japan Pneumococcal Polysaccharide Vaccine market, by type, 2015 - 2026 (USD Million)

    • Table Japan Pneumococcal Polysaccharide Vaccine market, by product, 2015 - 2026 (USD Million)

    • Table Japan Pneumococcal Polysaccharide Vaccine market, by application, 2015 - 2026 (USD Million)

    • Table Regulatory scenario

    • Table India Pneumococcal Polysaccharide Vaccine market, by type, 2015 - 2026 (USD Million)

    • Table India Pneumococcal Polysaccharide Vaccine market, by product, 2015 - 2026 (USD Million)

    • Table India Pneumococcal Polysaccharide Vaccine market, by application, 2015 - 2026 (USD Million)

    • Table Latin America Pneumococcal Polysaccharide Vaccine market, by country, 2015 - 2026 (USD Million)

    • Table Latin America Pneumococcal Polysaccharide Vaccine market, by type, 2015 - 2026 (USD Million)

    • Table Latin America Pneumococcal Polysaccharide Vaccine market, by product, 2015 - 2026 (USD Million)

    • Table Latin America Pneumococcal Polysaccharide Vaccine market, by application, 2015 - 2026 (USD Million)

    • Table Regulatory scenario

    • Table Brazil Pneumococcal Polysaccharide Vaccine market, by type, 2015 - 2026 (USD Million)

    • Table Brazil Pneumococcal Polysaccharide Vaccine market, by product, 2015 - 2026 (USD Million)

    • Table Brazil Pneumococcal Polysaccharide Vaccine market, by application, 2015 - 2026 (USD Million)

    • Table Regulatory scenario

    • Table Mexico Pneumococcal Polysaccharide Vaccine market, by type, 2015 - 2026 (USD Million)

    • Table Mexico Pneumococcal Polysaccharide Vaccine market, by product, 2015 - 2026 (USD Million)

    • Table Mexico Pneumococcal Polysaccharide Vaccine market, by application, 2015 - 2026 (USD Million)

    • Table Regulatory scenario

    • Table Argentina Pneumococcal Polysaccharide Vaccine market, by type, 2015 - 2026 (USD Million)

    • Table Argentina Pneumococcal Polysaccharide Vaccine market, by product, 2015 - 2026 (USD Million)

    • Table Argentina Pneumococcal Polysaccharide Vaccine market, by application, 2015 - 2026 (USD Million)

    • Table MEA Pneumococcal Polysaccharide Vaccine market, by country, 2015 - 2026 (USD Million)

    • Table MEA Pneumococcal Polysaccharide Vaccine market, by type, 2015 - 2026 (USD Million)

    • Table MEA Pneumococcal Polysaccharide Vaccine market, by product, 2015 - 2026 (USD Million)

    • Table MEA Pneumococcal Polysaccharide Vaccine market, by application, 2015 - 2026 (USD Million)

    • Table Regulatory scenario

    • Table South Africa Pneumococcal Polysaccharide Vaccine market, by type, 2015 - 2026 (USD Million)

    • Table South Africa Pneumococcal Polysaccharide Vaccine market, by product, 2015 - 2026 (USD Million)

    • Table South Africa Pneumococcal Polysaccharide Vaccine market, by application, 2015 - 2026 (USD Million)

    • Table Regulatory scenario

    • Table Nigeria Pneumococcal Polysaccharide Vaccine market, by type, 2015 - 2026 (USD Million)

    • Table Nigeria Pneumococcal Polysaccharide Vaccine market, by product, 2015 - 2026 (USD Million)

    • Table Nigeria Pneumococcal Polysaccharide Vaccine market, by application, 2015 - 2026 (USD Million)

    • Table Recent Developments & Impact Analysis, by Key Market Participants

    • Table Recent Developments & Impact Analysis, by Key Market Participants

    • Table Company market position analysis

    • Table Company Profiles

    • Table Merck & Co, Inc. Production, Value, Price, Gross Margin 2014-2019

    • Table Product benchmarking

    • Table Strategic initiatives

    • Table SWOT analysis

    • Table Company Profiles

    • Table Merck & Co., Inc. Production, Value, Price, Gross Margin 2014-2019

    • Table Product benchmarking

    • Table Strategic initiatives

    • Table SWOT analysis

    • Table Company Profiles

    • Table China National Biotec Group Production, Value, Price, Gross Margin 2014-2019

    • Table Product benchmarking

    • Table Strategic initiatives

    • Table SWOT analysis

    • Table Company Profiles

    • Table Glaxosmithkline Plc. Production, Value, Price, Gross Margin 2014-2019

    • Table Product benchmarking

    • Table Strategic initiatives

    • Table SWOT analysis

    • Table Company Profiles

    • Table Serum Institute of India Pvt. Ltd Production, Value, Price, Gross Margin 2014-2019

    • Table Product benchmarking

    • Table Strategic initiatives

    • Table SWOT analysis

    • Table Company Profiles

    • Table Pfizer Inc Production, Value, Price, Gross Margin 2014-2019

    • Table Product benchmarking

    • Table Strategic initiatives

    • Table SWOT analysis

    • Table Company Profiles

    • Table Astellas Pharma Inc Production, Value, Price, Gross Margin 2014-2019

    • Table Product benchmarking

    • Table Strategic initiatives

    • Table SWOT analysis

Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.

CONTACT US